Verona Pharma plc (VRNA)
NASDAQ: VRNA · IEX Real-Time Price · USD
16.50
+0.36 (2.23%)
At close: Mar 27, 2024, 4:00 PM
16.90
+0.40 (2.42%)
After-hours: Mar 27, 2024, 7:41 PM EDT

Verona Pharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018201720162015
Revenue
00.4640000000
Revenue Growth (YoY)
--98.86%-------
Cost of Revenue
00.350000000
Gross Profit
00.1140000000
Selling, General & Admin
50.3526.5833.9129.779.9987.673.172.17
Research & Development
17.2249.2879.4144.5142.4224.530.125.749.23
Operating Expenses
67.5775.86113.3174.2852.432.537.798.9211.4
Operating Income
-67.57-75.75-73.31-74.28-52.4-32.5-37.79-8.92-11.4
Interest Expense / Income
2.060.520.340.0401.683.131.010.09
Other Expense / Income
-15.73-7.82-18.07-9.31-11.91-3.53-8.91-2.34-0.06
Pretax Income
-53.9-68.45-55.59-65-40.49-30.65-32.01-7.59-11.44
Income Tax
0.470.25-0.020.150.07-5.37-5.98-1.21-1.92
Net Income
-54.37-68.7-55.57-65.15-40.56-25.27-26.03-6.37-9.52
Shares Outstanding (Basic)
634529480345105105103103-
Shares Outstanding (Diluted)
634529-------
Shares Change
19.86%10.20%39.23%227.37%0.29%2.20%---
EPS (Basic)
-0.72-1.04-0.96-2.00-3.12-1.92-2.38-1.52-3.77
EPS (Diluted)
-0.72-1.04-0.96-2.00-3.12-1.92-2.38-1.52-3.77
Free Cash Flow
-50.22-59.89-33.27-45.16-42.92-28.85-27.33-9.06-8.96
Free Cash Flow Per Share
-0.63-0.91-0.55-1.05-3.26-2.20-2.13-0.70-
Gross Margin
-24.45%100.00%------
Operating Margin
--16539.30%-183.28%------
Profit Margin
--15000.22%-138.92%------
Free Cash Flow Margin
--13076.64%-83.17%------
EBITDA
-51.16-67.29-54.62-64.34-39.98-28.96-28.87-6.56-11.33
EBITDA Margin
--14692.36%-136.55%------
Depreciation & Amortization
0.680.640.630.620.510.010.010.010.01
EBIT
-51.84-67.93-55.25-64.97-40.49-28.97-28.88-6.58-11.34
EBIT Margin
--14831.22%-138.12%------
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).